HAGEN BRETT R (Chief Accounting Officer) sold 3.3% of their position (96.00 shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $967.28 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2025ACC: 0000950170-25-025633
Officer· Chief Accounting Officer
Since Jul 2020
-96.00
Net shares
Net seller
$967.28
Total sold
1
Open market trades
0B · 1S
1
Total transactions
96.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−96.00
Price / share
$10.08
Trade value
$967.28
% of position
3.3%
2/21/2025
2.93K→2.83K
Total
Net shares
−96.00
Net value
-$967.28
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2025 | S · Sale | −96.00 | $10.08 | $967.28 | 3.3% | 2.93K | 2.83K |
| Total | −96.00 | -$967.28 | ||||||
Derivative Transactions0
No derivative transactions reported